Less than 10% of Alzheimer’s patients eligible for new antibody treatments
https://studyfinds.org/alzheimers-patients-treatments/
These drugs target amyloid-ß plaques in the brain, which are an early indication of Alzheimer’s.
https://studyfinds.org/alzheimers-patients-treatments/
https://studyfinds.org/hiv-cure-antibody-treatment/
https://studyfinds.org/drug-liver-disease-treatment/
https://studyfinds.org/pancreatic-cancer-immunotherapy/
https://studyfinds.org/float-therapy-anorexia-treatment/
https://studyfinds.org/new-material-cancer-treatments/